Robert C. Bast
Impact in
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
Papers in
-
- Ovarian cancer diagnosis and treatment 290
- Oncology 108
- HER2/EGFR in Cancer Research 32
- Cancer-related Molecular Pathways 18
- Co-authors
- Gordon Brent Mills (55 shared papers)ROBERT CHARLES KNAPP (45 shared papers)Ian J. Jacobs (30 shared papers)Andrew Berchuck (56 shared papers)Daniel F. Hayes (7 shared papers)Mark R. Somerfield (5 shared papers)Robert Gary Mennel (6 shared papers)Bryan T. Hennessy (4 shared papers)
- Journals
- Gynecologic Oncology (51 papers)Cancer (37 papers)American Journal of Obstetrics and Gynecology (34 papers)Journal of Clinical Oncology (22 papers)JNCI Journal of the National Cancer Institute (18 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Robert C. Bast
617 papers receiving 59.4k citations
Robert C. Bast's Hit Papers
Peers
Comparison fields: 5 of 186
- Reproductive Medicine 17.9k
- Cancer Research 7.5k
- Oncology 8.8k
- Epidemiology 7.1k
- Molecular Biology 11k
Countries citing papers authored by Robert C. Bast
This map shows the geographic impact of Robert C. Bast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Bast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Bast more than expected).
Fields of papers citing papers by Robert C. Bast
This network shows the impact of papers produced by Robert C. Bast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Bast. The network helps show where Robert C. Bast may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert C. Bast, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 626 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Hit paper breakdown → | 2016 | 4680 |
| 2 | Guidelines for the use and interpretation of assays for monitoring autophagy Hit paper breakdown → | 2012 | 3543 |
| 3 | Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Hit paper breakdown → | 2021 | 2067 |
| 4 | American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer Hit paper breakdown → | 2007 | 1839 |
| 5 | A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer Hit paper breakdown → | 1983 | 1811 |
| 6 | Reactivity of a monoclonal antibody with human ovarian carcinoma. Hit paper breakdown → | 1981 | 1415 |
| 7 | ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer Hit paper breakdown → | 2006 | 1296 |
| 8 | The biology of ovarian cancer: new opportunities for translation Hit paper breakdown → | 2009 | 1133 |
| 9 | Rethinking ovarian cancer: recommendations for improving outcomes Hit paper breakdown → | 2011 | 1046 |
| 10 | Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Hit paper breakdown → | 2015 | 927 |
| 11 | Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer Hit paper breakdown → | 2004 | 788 |
| 12 | The CA 125 tumour-associated antigen: a review of the literature Hit paper breakdown → | 1989 | 787 |
| 13 | 2000 | 724 | |
| 14 | 2001 | 724 | |
| 15 | A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Hit paper breakdown → | 2008 | 703 |
| 16 | Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Hit paper breakdown → | 2016 | 657 |
| 17 | Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Hit paper breakdown → | 1988 | 650 |
| 18 | 1996 | 619 | |
| 19 | The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass Hit paper breakdown → | 2007 | 579 |
| 20 | 2008 | 524 |
About Robert C. Bast
Robert C. Bast is a scholar working on Reproductive Medicine, Oncology, Cancer Research, Immunology and Hematology, having authored 626 papers that have together received 62.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (290 papers), HER2/EGFR in Cancer Research (32 papers), Hematopoietic Stem Cell Transplantation (29 papers), Breast Cancer Treatment Studies (26 papers), Immunotherapy and Immune Responses (25 papers), Autophagy in Disease and Therapy (25 papers), Cancer-related Molecular Pathways (18 papers) and Endometrial and Cervical Cancer Treatments (16 papers). The work is most often cited by research in Reproductive Medicine (17.9k citations), Cancer Research (7.5k citations), Oncology (8.8k citations), Epidemiology (7.1k citations) and Molecular Biology (11k citations). Robert C. Bast has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Gordon Brent Mills, ROBERT CHARLES KNAPP, Ian J. Jacobs, Andrew Berchuck, Daniel F. Hayes, Mark R. Somerfield, Robert Gary Mennel, Bryan T. Hennessy, Jonathan M. Niloff and Robert B. Colvin. Their work appears in journals such as Gynecologic Oncology, Cancer, American Journal of Obstetrics and Gynecology, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.